Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Barcelona willing to offer the Atlético de Madrid defender a new start next summer

Barcelona are analyzing potentially cheap options to complete their squad next summer, and one of the options they have identified is Atlético Madrid defender Reinildo Mandava. The 30-year-old Mozambican international expires next summer and looks set to leave Los Rojiblancos.

The Blaugrana have ruled out the idea of ​​betting on Trent Alexander-Arnold or Alphonso Davies due to the cost, but they are still looking to strengthen their full-back positions. Reinildo has played 18 games this season, but totaled only 957 minutes and 10 starts. This reflects the fact that Javi Galán has made the left-back position his own of late. MD says sporting director Deco is looking at Reinildo as a left-back option who can play in central defence.

In Atlético’s last 7 League and Champions League games, Reinildo has played just 45 minutes, and previous reports have claimed that Atlético are also willing to let him go in January. If he arrived, it seems likely that he would do so in a similar way to Marcos Alonso, who left for Celta Vigo last summer. Reinildo is more solid defensively than Alejandro Balde, but there are doubts about his attacking effectiveness in a high-possession system, which Barcelona tends to favor.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.